"En lo que se refiere al tratamiento, además de las técnicas más avanzadas de radiología, HM CIOCC cuenta con la unidad de investigación traslacional, que posibilita un abordaje personalizado de cada tipo de tumor. Ejemplos de servicios de máximo nivel en este sentido son la Unidad de Radiología de la Mujer o el Servicio de Oncología Radioterápica, con tres aceleradores lineales -uno de ellos casi único en España, que permite hacer cirugía intra y extracraneal-, un quirófano inteligente y braquiterapia. HM CIOCC también cuenta con un área dedicada a investigación, tanto el Laboratorio de Dianas Terapéuticas como en el Servicio de Oncología Radioterápica."

During the past decade, Hospital Universitario HM Madrid Sanchinarro - Servicio de Oncologia conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario HM Madrid Sanchinarro - Servicio de Oncologia" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 4 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario HM Madrid Sanchinarro - Servicio de Oncologia" are "Biliary Tract Cancer" (2 trials), "Cholangiocarcinoma" (2 trials), "Gallbladder Cancer" (2 trials), "Non-small Cell Lung Cancer" (2 trials) and "Advanced/Metastatic Tumors" (1 trials). Many other conditions were trialed in "Hospital Universitario HM Madrid Sanchinarro - Servicio de Oncologia" in a lesser frequency.

Most popular intervention types in "Hospital Universitario HM Madrid Sanchinarro - Servicio de Oncologia" are "Drug" (7 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cisplatin" (5 trials), "Carboplatin" (3 trials), "Gemcitabine" (3 trials), "M7824" (3 trials) and "Pemetrexed" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario HM Madrid Sanchinarro - Servicio de Oncologia" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Universitario HM Madrid Sanchinarro - Servicio de Oncologia". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hospital Universitario HM Madrid Sanchinarro - Servicio de Oncologia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario HM Madrid Sanchinarro - Servicio de Oncologia, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".